ICU sedation, delirium & recovery
The EyeControl-Med device, an alternative tool for communication in ventilated critically ill patients: A pilot study examining communication capabilities and delirium
Authors' conclusion
The EyeControl-Med device may facilitate communication and reduce the manifestations and duration of delirium in ventilated critically ill patients.
Study context
- Population
- Invasively ventilated and/or tracheotomized Intensive care unit (ICU) patients unable to generate speech, without severe cognitive or sensory impairment, mixed ICU40% COVID-19
- Participants
- 15 participants
- Comparison
- First vs last session with the EyeControl-Med device
- EyeControl-Medn = 15
- Outcome
- Communication capabilities (Loewenstein Communication Scale, LCS) and delirium incidence (computerized CAM-ICU questionnaire)
- Follow-up
- First and last sessions
Methodological detailsexploratory concept study, All patients completed three to seven usage sessions
- Exploratory concept study
- All patients completed three to seven usage sessions
Main finding
As reported in the abstract
Mean Loewenstein Communication Scale (LCS) score improved (p < 0.0001); each of its five components significantly improved
19.3 points
Mean number of errors on CAM-ICU questionnaire decreased (p = 0.0006), indicating lower delirium incidence
6.5 to 2.5
Safety
- No adverse effects were observed
Original publication
The EyeControl-Med device, an alternative tool for communication in ventilated critically ill patients: A pilot study examining communication capabilities and delirium. J Crit Care. Published 21 June 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →